Subject Index Volume 170
3
Subject Index Volume 170 (2013) Adenovirus, (170) 132 Activation energy, (170) 175 Acyclovir monophosphate, (170) 414 Adhesive nanoparticle, (170) 198 Akt, (170) 287 Albumin, (170) 219 Alzheimer's disease, (170) 111 and permeation, (170) 268 Animal model, (170) 111 Antibodies, (170) 242 Antibody production, (170) 259 Anticancer, (170) 15 Antigen delivery, (170) 242 Antipsoriatic drugs, (170) 380 Apolipoproteins, (170) 167 Apoptosis, (170) 287 Azoxystrobin, (170) 242 Bacteria, (170) 120 BDEPT, (170) 120 Bioadhesion, (170) 477 Biomaterials, (170) 242 Bone morphogenetic protein-2, (170) 198 Caffeine, (170) 175 Calcium phosphate, (170) 414 Cancer therapy, (170) 74 Cancer, (170) 120, (170) 183, (170) 209, (170) 365, (170) 396, (170) 469 Carbon nanotubes, (170) 242, (170) 295 Cardiomyocyte, (170) 287 Cationic oligonucleotides, (170) 92 Cell culture, (170) 334 Cell cycle, (170) 183 Cell encapsulation, (170) 1 Cell therapy, (170) 1 Cell-penetrating peptide, (170) 83 Cell-permeable peptide, (170) 437 Chemically modified siRNA, (170) 92 Chitosan, (170) 226 Chlorpromazine, (170) 343 Cholesteryl-siRNA, (170) 92 Chondrogenic differentiation, (170) 99 Clinic, (170) 1 Co-delivery, (170) 268 Colloidal carriers, (170) 380 Complement system, (170) 167 Conjugates, (170) 226 Controlled drug delivery, (170) 64 Copper-catalyzed alkyne-azide cycloaddition, (170) 219 CpG, (170) 307 Cyclodextrin, (170) 316 Cyclosporine A, (170) 153 Cytokines, (170) 380 Cytoplasmic release, (170) 307 Cytotoxic T-lymphocyte response, (170) 259 Cytotoxicity, (170) 295 Delivery, (170) 183 Dendrimers, (170) 141 Dendritic cells, (170) 259 Dendrosomes, (170) 141 Dental implant, (170) 198 Diabetes, (170) 191, (170) 430 Dicer, (170) 307 Diffusion, (170) 175 Dissolving polymer, (170) 430 Doxorubicin, (170) 316 Droplet-born air blowing, (170) 430 Drug delivery system, (170) 373 Drug delivery, (170) 1, (170) 83, (170) 279, (170) 316, (170) 343, (170) 396, (170) 430 Drug release mechanism, (170) 175 Drug release, (170) 268 Elastin-like polypeptide, (170) 373 Electrospinning, (170) 64 Emulsification, (170) 279 Endocytosis, (170) 83 Endosomal escape, (170) 307 Ex vivo permeation, (170) 153 Exendin-4, (170) 226 Eye, (170) 153 Factor X, (170) 132 Fatty acid, (170) 219 Fenretinide, (170) 445 Fluorescent dye, (170) 334 Formulation, (170) 209 Fusidic acid, (170) 64 GastroPlus, (170) 15 Gene delivery, (170) 209, (170) 252, (170) 325, (170) 421, (170) 452, (170) 469 Gene therapy, (170) 51, (170) 120 Gene transfection, (170) 401, (170) 437 Journal of Controlled Release 170 (2013) e12–e14 doi:10.1016/S0168-3659(13)00422-7 Contents lists available at ScienceDirect Journal of Controlled Release journal homepage: www.elsevier.com/locate/jconrel
Transcript of Subject Index Volume 170
Subject Index Volume 170 (2013)
Adenovirus, (170) 132Activation energy, (170) 175Acyclovir monophosphate, (170) 414Adhesive nanoparticle, (170) 198Akt, (170) 287Albumin, (170) 219Alzheimer's disease, (170) 111and permeation, (170) 268Animal model, (170) 111Antibodies, (170) 242Antibody production, (170) 259Anticancer, (170) 15Antigen delivery, (170) 242Antipsoriatic drugs, (170) 380Apolipoproteins, (170) 167Apoptosis, (170) 287Azoxystrobin, (170) 242
Bacteria, (170) 120BDEPT, (170) 120Bioadhesion, (170) 477Biomaterials, (170) 242Bone morphogenetic protein-2, (170) 198
Caffeine, (170) 175Calcium phosphate, (170) 414Cancer therapy, (170) 74Cancer, (170) 120, (170) 183, (170) 209, (170) 365, (170) 396,
(170) 469Carbon nanotubes, (170) 242, (170) 295Cardiomyocyte, (170) 287Cationic oligonucleotides, (170) 92Cell culture, (170) 334Cell cycle, (170) 183Cell encapsulation, (170) 1Cell therapy, (170) 1Cell-penetrating peptide, (170) 83Cell-permeable peptide, (170) 437Chemically modified siRNA, (170) 92Chitosan, (170) 226Chlorpromazine, (170) 343Cholesteryl-siRNA, (170) 92Chondrogenic differentiation, (170) 99Clinic, (170) 1Co-delivery, (170) 268Colloidal carriers, (170) 380Complement system, (170) 167Conjugates, (170) 226
Controlled drug delivery, (170) 64Copper-catalyzed alkyne-azide cycloaddition, (170) 219CpG, (170) 307Cyclodextrin, (170) 316Cyclosporine A, (170) 153Cytokines, (170) 380Cytoplasmic release, (170) 307Cytotoxic T-lymphocyte response, (170) 259Cytotoxicity, (170) 295
Delivery, (170) 183Dendrimers, (170) 141Dendritic cells, (170) 259Dendrosomes, (170) 141Dental implant, (170) 198Diabetes, (170) 191, (170) 430Dicer, (170) 307Diffusion, (170) 175Dissolving polymer, (170) 430Doxorubicin, (170) 316Droplet-born air blowing, (170) 430Drug delivery system, (170) 373Drug delivery, (170) 1, (170) 83, (170) 279, (170) 316, (170) 343,
(170) 396, (170) 430Drug release mechanism, (170) 175Drug release, (170) 268
Elastin-like polypeptide, (170) 373Electrospinning, (170) 64Emulsification, (170) 279Endocytosis, (170) 83Endosomal escape, (170) 307Ex vivo permeation, (170) 153Exendin-4, (170) 226Eye, (170) 153
Factor X, (170) 132Fatty acid, (170) 219Fenretinide, (170) 445Fluorescent dye, (170) 334Formulation, (170) 209Fusidic acid, (170) 64
GastroPlus, (170) 15Gene delivery, (170) 209, (170) 252, (170) 325, (170) 421,
(170) 452, (170) 469Gene therapy, (170) 51, (170) 120Gene transfection, (170) 401, (170) 437
Journal of Controlled Release 170 (2013) e12–e14
doi:10.1016/S0168-3659(13)00422-7
Contents lists available at ScienceDirect
Journal of Controlled Release
j ourna l homepage: www.e lsev ie r.com/ locate / jconre l
Gold nanorods, (170) 41GRP78, (170) 41
Half-life, (170) 219Heart failure, (170) 287Heat-triggered drug release, (170) 373Heparan sulfate proteoglycan, (170) 83High density lipoprotein, (170) 167High speed videomicroscopy, (170) 401High-content analysis, (170) 295HIV-1, (170) 452HPMA copolymers, (170) 41Hyaluronan, (170) 295Hybrid nanoparticles, (170) 51Hydrodynamic dosing, (170) 325Hydrophobic interaction, (170) 469Hydroxypropyl methylcellulose, (170) 175Hyperglycemia, (170) 191Hyperthermia, (170) 41, (170) 316Hypotonic dialysis, (170) 343
Immune response, (170) 295Immunity, (170) 452Immunization, (170) 242In vivo distribution, (170) 153In-vitro in-vivo correlation, (170) 477Indomethacin, (170) 268Inflammatory diseases, (170) 460Influenza, (170) 452Innate immunity, (170) 167Insulin-like growth factor-1, (170) 287Insulin, (170) 358Intracellular delivery, (170) 401Intravesical drug delivery, (170) 161Ischemia–reperfusion, (170) 352
Labeling of nanocarrier, (170) 334Lentivirus, (170) 421Light scattering, (170) 334Lipid nanocapsule, (170) 334Lipophilic siRNA, (170) 92Liposomes, (170) 141, (170) 233, (170) 343Live imaging, (170) 352Localized delivery, (170) 252Low density lipoprotein, (170) 167
Macrophage targeting, (170) 460Mechanism of action, (170) 365Mechanism of delivery, (170) 365Mesenchymal stem cells, (170) 99Metabolic labeling, (170) 83Metastasis, (170) 183Microbubbles, (170) 401Microneedle, (170) 430Mild hyperthermia, (170) 373Mini-mould, (170) 161Mini-tablet, (170) 161Molecular recognition, (170) 141MRI guided Focused Ultrasound, (170) 316Mucosal, (170) 452Mucus-penetrating particles, (170) 279Multiple channel bridge, (170) 421Myocardial infarction, (170) 437
nab-Paclitaxel, (170) 365Nanocarriers, (170) 209, (170) 233Nanocolloidal systems, (170) 380Nanofibers, (170) 64Nanoliposomes, (170) 445
Nanomedicine, (170) 279Nanoparticle, (170) 396, (170) 268, (170) 352, (170) 414, (170) 477Nanoparticles, (170) 15, (170) 74, (170) 111Nasal absorption, (170) 358Neuroblastoma, (170) 233, (170) 445Noncanonical amino acid, (170) 219
Oral delivery, (170) 15, (170) 74, (170) 226Overactive bladder, (170) 161
Peptides, (170) 226, (170) 233Percutaneous delivery, (170) 51Permeability, (170) 15pH-sensitive vector, (170) 252pH, (170) 396Phage display screening, (170) 233Pharmacologically active microcarriers, (170) 99PLGA, (170) 111PLGA/PVA nanospheres, (170) 460Poloxamer 407, (170) 167Polyamine, (170) 396Polyethylene glycol, (170) 325Polypeptide micelles, (170) 259Polyplexes, (170) 209Polysaccharide, (170) 421Porous silicon, (170) 268PPARγ agonists, (170) 460Prodrug, (170) 120, (170) 153Prostate cancer, (170) 41Protein encapsulation, (170) 99Protein kinase, (170) 469Protein transduction domain (PTD), (170) 358Psoriasis like mouse model, (170) 51Psoriasis, (170) 380PYY3-36, (170) 268
Reactive oxygen species, (170) 191, (170) 352Recombinant adeno-associated virus, (170) 252Red blood cells, (170) 343Rifampicin, (170) 64RNA interference, (170) 92
Scaffold, (170) 421siRNA, (170) 51, (170) 307Skin inflammation, (170) 51Small molecule inhibitors, (170) 132Solid lipid extrusion, (170) 161Solubility, (170) 15Sonoporation, (170) 316, (170) 401Spinal cord injury, (170) 421Spleen-mimicking device, (170) 343Stem cells, (170) 1Stereochemistry, (170) 83Sticky siRNA, (170) 183Stroke, (170) 352Surface functionalization, (170) 198Surface PEG density, (170) 279Swelling, (170) 175
Targeted drug delivery, (170) 41Targeted therapy, (170) 233, (170) 445Taurocholic acid, (170) 74Taxane, (170) 365TCTP-PTD, (170) 358Thermosensitive liposome, (170) 373Titanium, (170) 198TLR9, (170) 307Transduction, (170) 252Transforming growth factor, (170) 99
e13Subject Index Volume 167 (2013) e12–e13
Transgene regulation, (170) 469Translationally controlled tumor protein (TCTP), (170) 358Trospium chloride, (170) 161Tumor metastasis, (170) 191Tumor therapy, (170) 414Tumor, (170) 396Type 2 diabetes, (170) 226
Ultrasound-targeted microbubble destruction, (170) 437Ultrasound, (170) 401Uptake, (170) 477
Vaccination, (170) 452Vaccine adjuvant, (170) 259Vascular targeting, (170) 445VEGF, (170) 111Vesosomes, (170) 141
Water formulation, (170) 153
2NA, (170) 92
e14Subject Index Volume 167 (2013) e12–e13
![INDEX [gov.mb.ca] · 2019-01-25 · The index is in two sections: (1) Subject index, and (2) Appendices. Subject Index: Main entry in this section is a subject heading which may be](https://static.fdocuments.net/doc/165x107/5eca5e82200d5a04fc371c88/index-govmbca-2019-01-25-the-index-is-in-two-sections-1-subject-index.jpg)
